Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitomycin-C in congenital glaucoma

H C Agarwal1, N N Sood, R Sihota

  • 1Glaucoma Service, Dr. Rajendra Prasad Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Ophthalmic Surgery and Lasers
|January 15, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term outcome of combined trabeculotomy-trabeculectomy by a single surgeon in patients with primary congenital glaucoma.

Eye (London, England)·2017
Same author

Capsular neovascularisation: case report and review of literature.

Eye (London, England)·2014
Same author

Persistence of DDT and nature of bound residues in soil at higher altitude.

Environmental science & technology·2012
Same author

Ab-externo cyclodialysis enhanced trabeculectomy for intractable post-penetrating keratoplasty glaucoma.

Eye (London, England)·2009
Same author

Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection.

Eye (London, England)·2007
Same author

Effect of UV radiation and temperature on mineralization and volatilization of coumaphos in water.

Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes·2007
Same journal

Bilateral cataract surgery combined with implantation of a brown diaphragm intraocular lens after trabeculectomy for congenital aniridia.

Ophthalmic surgery and lasers·2002
Same journal

Macular hole following photodynamic therapy.

Ophthalmic surgery and lasers·2002
Same journal

Vitreous surgery for bilateral bullous retinal detachment in Vogt-Koyanagi-Harada syndrome.

Ophthalmic surgery and lasers·2002
Same journal

Combination of Nd:Yag laser-induced subconjunctival bleeding and intracameral viscoelastic injection to treat hypotony maculopathy.

Ophthalmic surgery and lasers·2002
Same journal

Surgical management of a dysfunctional filtering bleb.

Ophthalmic surgery and lasers·2002
Same journal

Partial excision with a conjunctival advancement flap after a relaxing incision for a dissecting glaucoma filtering bleb.

Ophthalmic surgery and lasers·2002
See all related articles

Mitomycin-C (MMC) at 0.2 mg/ml effectively controlled intraocular pressure in congenital glaucoma surgery, similar to 0.4 mg/ml. The lower concentration resulted in fewer complications and thinner blebs.

Area of Science:

  • Ophthalmology
  • Glaucoma Surgery
  • Ocular Pharmacology

Background:

  • Congenital glaucoma presents significant challenges in intraocular pressure (IOP) management.
  • Trabeculotomy and trabeculectomy are common surgical interventions for congenital glaucoma.
  • The adjunctive use of mitomycin-C (MMC) aims to enhance surgical outcomes.

Purpose of the Study:

  • To evaluate the efficacy and safety of different concentrations of mitomycin-C (MMC) as an adjunct in trabeculotomy and trabeculectomy for high-risk congenital glaucoma.
  • To compare the impact of 0.2 mg/ml versus 0.4 mg/ml MMC on postoperative IOP control and surgical success rates.

Main Methods:

  • A prospective, randomized, double-blind study involving 16 high-risk congenital glaucoma cases (30 eyes).
  • Patients were randomized to receive either 0.2 mg/ml (group 1) or 0.4 mg/ml (group 2) of MMC during surgery.

Related Experiment Videos

  • Intraocular pressures (IOPs) and surgical outcomes were monitored postoperatively.

    • Main Results:

    • Both MMC concentrations achieved similar IOP control with medication (86.7% in each group).
    • Without medication, 60% of eyes in group 1 and 86.67% in group 2 achieved IOP control (< 21 mm Hg).
    • Avascular, thin blebs were more frequent in group 2 (66.67%) compared to group 1 (33.3%). Complications like hyphema and hypotony occurred in both groups, with serous choroidal detachment and wound leakage noted in group 2.

    Conclusions:

    • Intraoperative mitomycin-C (MMC) at 0.2 mg/ml is as effective as 0.4 mg/ml for IOP control in high-risk congenital glaucoma.
    • The lower concentration (0.2 mg/ml) is associated with a reduced incidence of complications and thinner-walled blebs.